ConductScience.org, home

Paper39711784

Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.

Hernández-García M and 15 others. Front Cell Infect Microbiol, 2024. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences. Papers, record 39711784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39711784

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unravelling the mechanisms causing murepavadin resistance in Pseudomonas aeruginosa: lipopolysaccharide alterations and its consequences.
PubMed
Journal
Front Cell Infect Microbiol
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
1.72, provisional
iCite
Revised in PubMed
2026-11-06
PubMed

Authors16

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hernández-García MMarta
2Barbero-Herranz RRaquel
3Bastón-Paz NNatalia
4Díez-Aguilar MMaría
5López-Collazo EEduardo
6Márquez-Garrido FJFrancesc J
7Hernández-Pérez JMJosé María
8Baquero FFernando
9Ekkelenkamp MBMiquel B
10Fluit ACAd C
11Fuentes-Valverde VVíctor
12Moscoso MMiriam
13Bou GGermán
14Del Campo RRosa
15Cantón RRafael
16Avendaño-Ortiz JJosé

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pseudomonas aeruginosaMajor topic
Microbial Sensitivity TestsMajor topic
Drug Resistance, BacterialMajor topic
LipopolysaccharidesMajor topic
Lipid AMajor topic
Anti-Bacterial AgentsMajor topic
ColistinMajor topic
Genome-Wide Association StudyMajor topic
Bacterial ProteinsMajor topic
Humans
Pseudomonas Infections
Antimicrobial Cationic Peptides
Cathelicidins
Mutation
Acyltransferases
Peptides, Cyclic

Source PubMed

Download CSV of topics

References60

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131849667Snake Venom Cathelicidins as Natural Antimicrobial Peptides.Front Pharmacol2019https://conductscience.org/library/papers/31849667PubMed
216998183Covalent binding of the natural antimicrobial peptide indolicidin to DNA abasic sites.Nucleic Acids Res2006https://conductscience.org/library/papers/16998183PubMed
329451043Murepavadin: a new antibiotic class in the pipeline.Expert Rev Anti Infect Ther2018https://conductscience.org/library/papers/29451043PubMed
419752280Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19752280PubMed
529359918A Peptidomimetic Antibiotic Interacts with the Periplasmic Domain of LptD from Pseudomonas aeruginosa.ACS Chem Biol2018https://conductscience.org/library/papers/29359918PubMed
626223882Site-specific activity of the acyltransferases HtrB1 and HtrB2 in Pseudomonas aeruginosa lipid A biosynthesis.Pathog Dis2015https://conductscience.org/library/papers/26223882PubMed
725846400Extracellular zinc induces phosphoethanolamine addition to Pseudomonas aeruginosa lipid A via the ColRS two-component system.Mol Microbiol2015https://conductscience.org/library/papers/25846400PubMed
818556795Induction by cationic antimicrobial peptides and involvement in intrinsic polymyxin and antimicrobial peptide resistance, biofilm formation, and swarming motility of PsrA in Pseudomonas aeruginosa.J Bacteriol2008https://conductscience.org/library/papers/18556795PubMed
924065161Influence of lipid A acylation pattern on membrane permeability and innate immune stimulation.Mar Drugs2013https://conductscience.org/library/papers/24065161PubMed
1036290075Antimicrobial Peptides-Mechanisms of Action, Antimicrobial Effects and Clinical Applications.Antibiotics (Basel)2022https://conductscience.org/library/papers/36290075PubMed
1130442491Pseudomonas aeruginosa colonization causes PD-L1 overexpression on monocytes, impairing the adaptive immune response in patients with cystic fibrosis.J Cyst Fibros2019https://conductscience.org/library/papers/30442491PubMed
1231383668Production of Norspermidine Contributes to Aminoglycoside Resistance in pmrAB Mutants of Pseudomonas aeruginosa.Antimicrob Agents Chemother2019https://conductscience.org/library/papers/31383668PubMed
1316352835The Pseudomonas aeruginosa lipid A deacylase: selection for expression and loss within the cystic fibrosis airway.J Bacteriol2006https://conductscience.org/library/papers/16352835PubMed
1434248979Murepavadin, a Small Molecule Host Defense Peptide Mimetic, Activates Mast Cells via MRGPRX2 and MrgprB2.Front Immunol2021https://conductscience.org/library/papers/34248979PubMed
1535350118Realistic and critical review of the state of systemic antimicrobial peptides.ADMET DMPK2022https://conductscience.org/library/papers/35350118PubMed
1626345428On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death.Integr Biol (Camb)2015https://conductscience.org/library/papers/26345428PubMed
1735018535Indolicidin revisited: biological activity, potential applications and perspectives of an antimicrobial peptide not yet fully explored.World J Microbiol Biotechnol2022https://conductscience.org/library/papers/35018535PubMed
1817763333Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.J Infect Dis2007https://conductscience.org/library/papers/17763333PubMed
1932100713Benchmarking bacterial genome-wide association study methods using simulated genomes and phenotypes.Microb Genom2020https://conductscience.org/library/papers/32100713PubMed
2014620153Cathelicidins and innate defense against invasive bacterial infection.Scand J Infect Dis2003https://conductscience.org/library/papers/14620153PubMed

See all 60 referencesDownload CSV of references

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
42750372Peptide-Enabled Nanoplatforms for Malaria and Leishmaniasis: From Intracellular Targeting to Translational Diagnostic Perspectives.ChemMedChem2026https://conductscience.org/library/papers/42750372PubMed
42388494Bacterial mutation dynamics emerging insights into virulence evolution and drug resistance. A review study.Front Med (Lausanne)2026https://conductscience.org/library/papers/42388494PubMed
42306526Engineering low-endotoxin lipid A in a double auxotroph Pseudomonas aeruginosa to develop safer whole-cell vaccines.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42306526PubMed
41901741Glnk Mediates Carbapenem Resistance Through the NtrB/NtrC-OprD Regulatory Pathway in Pseudomonas aeruginosa.Pathogens2026https://conductscience.org/library/papers/41901741PubMed
41594104Natural and Synthetic Peptides as Alternatives to Antibiotics in Intestinal Infections-A Review.Antibiotics (Basel)2026https://conductscience.org/library/papers/41594104PubMed
41495674Genomic variants distinguish Pseudomonas aeruginosa from cystic fibrosis sputum and bloodstream infection.BMC Infect Dis2026https://conductscience.org/library/papers/41495674PubMed
41303349Protein-Protein Interactions as Promising Molecular Targets for Novel Antimicrobials Aimed at Gram-Negative Bacteria.Int J Mol Sci2025https://conductscience.org/library/papers/41303349PubMed
41181323LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41181323PubMed

Download CSV of cited by

Data2

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
BioProjectPRJNA527751BioProject
BioProjectPRJNA530912BioProject

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39711784

GET https://conductscience.org/api/papers/v1/39711784/references?page=2